Another important point arising from this systematic review is that ICS can be ineffective in preventing AHR in smoking patients with asthma, a condition related to the presence of relative steroid resistance due to the impairment of histone deacetylase 2 (HDAC2) [28,46]. Here, HDAC2 is linked to asthma.